GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $42,000 | +90.9% | 192 | 0.0% | 0.00% | – |
| Q4 2020 | $22,000 | -12.0% | 192 | -24.7% | 0.00% | – |
| Q3 2020 | $25,000 | +4.2% | 255 | +32.8% | 0.00% | – |
| Q2 2020 | $24,000 | -53.8% | 192 | -67.6% | 0.00% | – |
| Q1 2020 | $52,000 | -18.8% | 592 | -3.4% | 0.00% | – |
| Q4 2019 | $64,000 | -8.6% | 613 | +1.2% | 0.00% | – |
| Q3 2019 | $70,000 | -32.7% | 606 | 0.0% | 0.00% | – |
| Q2 2019 | $104,000 | +2.0% | 606 | 0.0% | 0.00% | – |
| Q1 2019 | $102,000 | +75.9% | 606 | +2.5% | 0.00% | – |
| Q4 2018 | $58,000 | -39.6% | 591 | +6.3% | 0.00% | – |
| Q3 2018 | $96,000 | +23.1% | 556 | 0.0% | 0.00% | – |
| Q2 2018 | $78,000 | +333.3% | 556 | +256.4% | 0.00% | – |
| Q1 2018 | $18,000 | -5.3% | 156 | +9.9% | 0.00% | – |
| Q4 2017 | $19,000 | +35.7% | 142 | 0.0% | 0.00% | – |
| Q3 2017 | $14,000 | 0.0% | 142 | 0.0% | 0.00% | – |
| Q2 2017 | $14,000 | +100.0% | 142 | +84.4% | 0.00% | – |
| Q2 2016 | $7,000 | +75.0% | 77 | +54.0% | 0.00% | – |
| Q1 2016 | $4,000 | -20.0% | 50 | 0.0% | 0.00% | – |
| Q3 2015 | $5,000 | -16.7% | 50 | 0.0% | 0.00% | – |
| Q2 2015 | $6,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |